How Has Brexit Affected Pharmaceutical Distribution in the UK?
Understanding the impact that Brexit can have on our way of life can seem very daunting at first, but when it comes down to the finer details such as the distribution of medication, there is a lot that could be about to change. In this article, we will be providing you with insight into how the pharmaceutical distribution process will be affected by Brexit.
Changes To International Regulations
When looking at the impact that Brexit can have on our lives in the UK at the end of this year can seem quite daunting at first. However, within the pharmaceutical sector, there is set to be the most amount of change. Not only are there changes to distribution itself, but there are also changes to international regulations that are set to revolutionize the distribution of medication and PPE between the UK and Europe. Though there has been nothing set in stone regarding these changes in regulation at this time, the end of the year could reveal a deal that has been made.
Trade of Pharmaceuticals with the EU
It is important to remember at this time that the UK has had a long history of trading with the EU for PPE and medication. Figures have shown that in 2016 alone the UK exported £24.9 billion in pharmaceutical goods. With Brexit however, this could be set to change as regulations and tariffs on trading goods could lead to a significant drop in the amount of revenue that the UK brings in every year.